Search research articles
Contact Us
Filters
Showing results (41-50 of 80) with videos related to
Page
of 8
Sort By:
Functional Neurology
|
August 10, 2001
Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis
R Horowski, C S Stürzebecher, J F Kapp
Acta Endocrinologica
|
June 1, 1977
Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats
K J Gräf, R Horowski, M F Etreby
Lancet (London, England)
|
July 9, 1983
Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors
R Dorow, R Horowski, G Paschelke, et al.
Archiv Der Pharmazie
|
January 1, 1978
[Dopamine analogous 1,2,3,4-tetrahydro-beta-carbolines (author's transl)]
K Rehse, H Schulte-Sienbeck, R Schmiechen, et al.
Acta Endocrinologica
|
April 1, 1986
Rapid regression of macroprolactinomas by the new dopamine partial agonist terguride
K J Gräf, D Köhler, R Horowski, et al.
Archiv Der Pharmazie
|
October 1, 1978
[Neuropharmacological investigation of a new antidopaminergic tetrahydro-beta-carboline (DTHN) (author's transl)]
W Kehr, R Horowski, H Schulte-Sienbeck, et al.
European Neurology
|
January 1, 1985
Effects of lisuride on blink reflex habituation in Parkinson disease
G Sandrini, E Alfonsi, E Martignoni, et al.
The European Journal of Neuroscience
|
June 1, 1994
The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease
J A Obeso, F Grandas, M T Herrero, et al.
Clinical Endocrinology
|
September 1, 1982
Effect of metoclopramide and lisuride on hypophyseal and gonadal function in men
K J Gräf, M Schmidt-Gollwitzer, R Horowski, et al.
Journal of Neural Transmission. Supplementum
|
September 10, 2004
Transdermal lisuride delivery in the treatment of Parkinson's disease
D Woitalla, T Müller, S Benz, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 80) with videos related to
Sort By:
Page
of 8
Functional Neurology
|
August 10, 2001
Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis
R Horowski, C S Stürzebecher, J F Kapp
Acta Endocrinologica
|
June 1, 1977
Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats
K J Gräf, R Horowski, M F Etreby
Lancet (London, England)
|
July 9, 1983
Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors
R Dorow, R Horowski, G Paschelke, et al.
Archiv Der Pharmazie
|
January 1, 1978
[Dopamine analogous 1,2,3,4-tetrahydro-beta-carbolines (author's transl)]
K Rehse, H Schulte-Sienbeck, R Schmiechen, et al.
Acta Endocrinologica
|
April 1, 1986
Rapid regression of macroprolactinomas by the new dopamine partial agonist terguride
K J Gräf, D Köhler, R Horowski, et al.
Archiv Der Pharmazie
|
October 1, 1978
[Neuropharmacological investigation of a new antidopaminergic tetrahydro-beta-carboline (DTHN) (author's transl)]
W Kehr, R Horowski, H Schulte-Sienbeck, et al.
European Neurology
|
January 1, 1985
Effects of lisuride on blink reflex habituation in Parkinson disease
G Sandrini, E Alfonsi, E Martignoni, et al.
The European Journal of Neuroscience
|
June 1, 1994
The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease
J A Obeso, F Grandas, M T Herrero, et al.
Clinical Endocrinology
|
September 1, 1982
Effect of metoclopramide and lisuride on hypophyseal and gonadal function in men
K J Gräf, M Schmidt-Gollwitzer, R Horowski, et al.
Journal of Neural Transmission. Supplementum
|
September 10, 2004
Transdermal lisuride delivery in the treatment of Parkinson's disease
D Woitalla, T Müller, S Benz, et al.
Page
of 8